Long-term Asthma Control Medications Accounting for Sizeable Share in Asthma Treatment Market
Long-term asthma control medications are projected to witness a sluggish CAGR of around 2.6% during the forecast period (2020-2027). Despite this, sales performance of these medications would remain significantly high as compared to quick-relief medications, as asthma patients are required to follow a strict medication regime. As a result, quick-relief medications would witness limited adoption at an estimated CAGR of around 1.7% during the forecast period.
Demand prospects for asthma therapeutics are likely to gain strength, owing to increasing awareness among patients regarding this condition. This should have led to linear growth of the asthma treatment market; however, a spurt in the sales of generic drugs, thriving on the back of patent expiration of branded drugs, is projected to limit market potential.
A recent study has been recently added to the broad report repository of Fact.MR, which portends that, the asthma treatment market would record a steady CAGR of 2.3% during the forecast period (2020-2027).
For detailed insights on market taxonomy, request a sample copy of the report here.
Growing Popularity of Alternative Therapies to Hinder Lucrative Opportunities for Market Players
Use of antibiotics for the treatment of asthma is debatable, as numerous pieces of literature highlight side-effects regarding their long-term consumption, such as dysphonia, sore throat, increased heart rate, and tremors. This is encouraging patients to adopt alternative therapies as additional panacea to treat asthma.
Though alternative therapies lack designation as the mainstream treatment, Yoga, Unani, and similar therapies are witnessing high adoption in developed countries of North America. However, the trend of replying on alternative therapies is more pronounced in China and India, where these therapies received first recognition. As Asia Pacific is a key destination for medical tourism, the influence of alternative therapies from developing countries is projected to fast-penetrate developed regions, thereby inhibiting significant sales opportunities for market players.
For detailed regional analysis, request a sample copy of the report here.
North America to Hold Pole Position in Asthma Treatment Market; Asia Pacific Market to Gain Pace
North America would retain its pole position in the asthma treatment market, while the market in Asia Pacific is projected to witness the fastest growth rate. During the forecast period, North America would lose its market share to Asia Pacific, as leading players are gradually scrambling towards developing countries such as China and India to cash in on relatively cost-effective production opportunities. For instance, F.Hoffmann-La Roche Ltd. announced the inauguration of a new manufacturing facility for its pharmaceutical division in Shanghai, China.
Additionally, North America accounts for a high concentration of leading players; ones that generally develop branded drugs. On the contrary, players in the Asia Pacific asthma treatment market relatively hold a low market position, and are involved in the development of generic drugs. As a result, threat of patent expiration affects the North American market more adversely than Asia Pacific. On the back of shifting market trends towards Asia Pacific, the regional asthma treatment market is projected to gain significant pace during the forecast period.
Asthma Treatment Market – Scope of the Study
The study on the asthma treatment market is an exclusive study, which has been recently added to the broad report repository of Fact.MR. The study brings to light crucial influencers that have been influencing the growth of the asthma treatment market. This comprehensive study offers analytical insights pertaining to the recent developments in the asthma treatment market, through the analysis of historical data for the period of 2017-2019, while the duration 2020-2027 is considered as the forecast period.
Recalibration of revenue of the asthma treatment market has been carried out in terms of value (US$ Mn). This research report offers exclusive insights into the influential trends that hold high potential to shape the asthma treatment market during the forecast period. Besides this, the report also includes numerous macroeconomic and microeconomic growth indicators that support the growth of the asthma treatment market during the forecast period. This detailed guide offers crucial information into the key dynamics, along with their influence on the asthma treatment market during the forecast period.
The detailed report, in turn, brings to the fore, insightful information about key challenges and threats that could limit the growth potential of players in the asthma treatment market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global asthma treatment market. With a view of aiding stakeholders in the asthma treatment market, the study comprises a detailed section on the competition analysis.
This exclusive study offers a dashboard view of the asthma treatment market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the asthma treatment market have also been included in this comprehensive study.
For more insights, request sample of this report.
Asthma Treatment Market – Assessment of Key Segments
Authors of this comprehensive study have classified the asthma treatment market into key segments for an in-depth study of the market. Categorisation of the asthma treatment market is based on treatment type, route of administration, distribution channel, and region. This detailed study also offers information about the incremental opportunity present in the asthma treatment market during the forecast period. Key segments considered while studying the asthma treatment market include:
|
Treatment Type
|
Route of Administration
|
Distribution Channel
|
Region
|
|
Long-term Asthma Control Medications
- Combination Inhalers
- Inhaled Corticosteroids
- Long-acting Beta Agonists
- Leukotriene Modifiers
- Theophylline
- Others (reslizumab, benralizumab, etc.)
|
Inhaled
|
Hospital Pharmacies
|
North America
|
|
Quick-relief (Rescue) Medications
- Short-acting Beta Agonists
- Ipratropium (Atrovent)
- Oral & Intravenous Corticosteroids
|
Oral
|
Retail Pharmacies
|
Europe
|
|
|
Intravenous
|
Online Pharmacies
|
Asia Pacific
|
|
|
Subcutaneous
|
|
Latin America
|
|
|
|
|
Middle East & Africa
|
Revenue of the asthma treatment market has been estimated in terms of US$ Mn for the period of 2020 to 2027. In addition to this, compound annual growth rate (CAGR %) has been estimated for all segments during the forecast period 2020-2027, considering 2019 as the base year, in the asthma treatment market.
Analysts of the research report have studied the profiles of key companies operating in the asthma treatment market to get a thorough idea of the competitive landscape. Leading, prominent, and emerging players profiled in this exclusive study include Mylan N.V., Teva Pharmaceutical Industries, AstraZeneca PLC., Sunovion Pharmaceutical, Inc., Boehringer Ingelheim, Sanofi, F.Hoffmann-La Roche Ltd., Novartis International AG, GlaxoSmithKline PLC, and Merck & Co., Inc.
Asthma Treatment Market – Research Methodology
The primary objective of this exclusive study on the asthma treatment market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2027. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the asthma treatment market, and recalibrate the adoption rate of asthma treatment in key regions across the world. Top-down and bottom-up approaches have also been adopted by research analysts in order to validate data and statistics to offer accurate market information to stakeholders.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Asthma Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Asthma Treatment Market Analysis and Forecast, 2020–2027
5. Market Outlook
5.1. Pipeline Analysis
5.2. Reimbursement Scenario
5.3. Disease Prevalence with Key Countries
6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
6.3.1. Long-term Asthma Control Medications
6.3.1.1. Inhaled Corticosteroids
6.3.1.2. Leukotriene Modifiers
6.3.1.3. Long-acting Beta Agonists
6.3.1.4. Combination Inhalers
6.3.1.5. Theophylline
6.3.1.6. Others (reslizumab, benralizumab, etc.)
6.3.2. Quick-relief (rescue) Medications
6.3.2.1. Short-acting Beta Agonists
6.3.2.2. Ipratropium (Atrovent)
6.3.2.3. Oral and Intravenous Corticosteroids
6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type
7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2020–2027
7.3.1. Oral
7.3.2. Inhaled
7.3.3. Intravenous
7.3.4. Subcutaneous
7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration
8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel
9. Global Asthma Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Asthma Treatment Market Attractiveness, by Region
10. North America Asthma Treatment Market Analysis and Forecast
10.1. Introduction
10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
10.2.1. Long-term Asthma Control Medications
10.2.1.1. Inhaled Corticosteroids
10.2.1.2. Leukotriene Modifiers
10.2.1.3. Long-acting Beta Agonists
10.2.1.4. Combination Inhalers
10.2.1.5. Theophylline
10.2.1.6. Others (reslizumab, benralizumab, etc.)
10.2.2. Quick-relief (rescue) Medications
10.2.2.1. Short-acting Beta Agonists
10.2.2.2. Ipratropium (Atrovent)
10.2.2.3. Oral and Intravenous Corticosteroids
10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
10.3.1. Oral
10.3.2. Inhaled
10.3.3. Intravenous
10.3.4. Subcutaneous
10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Asthma Treatment Market Attractiveness Analysis
10.6.1. By Treatment Type
10.6.2. By Route of Administration
10.6.3. By Distribution Channel
10.6.4. By Country/Sub-region
11. Europe Asthma Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
11.2.1. Long-term Asthma Control Medications
11.2.1.1. Inhaled Corticosteroids
11.2.1.2. Leukotriene Modifiers
11.2.1.3. Long-acting Beta Agonists
11.2.1.4. Combination Inhalers
11.2.1.5. Theophylline
11.2.1.6. Others (reslizumab, benralizumab etc.)
11.2.2. Quick-relief (rescue) Medications
11.2.2.1. Short-acting Beta Agonists
11.2.2.2. Ipratropium (Atrovent)
11.2.2.3. Oral and Intravenous Corticosteroids
11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
11.3.1. Oral
11.3.2. Inhaled
11.3.3. Intravenous
11.3.4. Subcutaneous
11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Asthma Treatment Market Attractiveness Analysis
11.6.1. By Treatment Type
11.6.2. By Route of Administration
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Asthma Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
12.2.1. Long-term Asthma Control Medications
12.2.1.1. Inhaled Corticosteroids
12.2.1.2. Leukotriene Modifiers
12.2.1.3. Long-acting Beta Agonists
12.2.1.4. Combination Inhalers
12.2.1.5. Theophylline
12.2.1.6. Others (reslizumab, benralizumab etc.)
12.2.2. Quick-relief (rescue) Medications
12.2.2.1. Short-acting Beta Agonists
12.2.2.2. Ipratropium (Atrovent)
12.2.2.3. Oral and Intravenous Corticosteroids
12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
12.3.1. Oral
12.3.2. Inhaled
12.3.3. Intravenous
12.3.4. Subcutaneous
12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis
12.6.1. By Treatment Type
12.6.2. By Route of Administration
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Asthma Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
13.2.1. Long-term Asthma Control Medications
13.2.1.1. Inhaled Corticosteroids
13.2.1.2. Leukotriene Modifiers
13.2.1.3. Long-acting Beta Agonists
13.2.1.4. Combination Inhalers
13.2.1.5. Theophylline
13.2.1.6. Others (reslizumab, benralizumab etc.)
13.2.2. Quick-relief (rescue) Medications
13.2.2.1. Short-acting Beta Agonists
13.2.2.2. Ipratropium (Atrovent)
13.2.2.3. Oral and Intravenous Corticosteroids
13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
13.3.1. Oral
13.3.2. Inhaled
13.3.3. Intravenous
13.3.4. Subcutaneous
13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Asthma Treatment Market Attractiveness Analysis
13.6.1. By Treatment Type
13.6.2. By Route of Administration
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Asthma Treatment Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
14.2.1. Long-term Asthma Control Medications
14.2.1.1. Inhaled Corticosteroids
14.2.1.2. Leukotriene Modifiers
14.2.1.3. Long-acting Beta Agonists
14.2.1.4. Combination Inhalers
14.2.1.5. Theophylline
14.2.1.6. Others (reslizumab, benralizumab etc.)
14.2.2. Quick-relief (rescue) Medications
14.2.2.1. Short-acting Beta Agonists
14.2.2.2. Ipratropium (Atrovent)
14.2.2.3. Oral and Intravenous Corticosteroids
14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
14.3.1. Oral
14.3.2. Inhaled
14.3.3. Intravenous
14.3.4. Subcutaneous
14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis
14.6.1. By Treatment Type
14.6.2. By Route of Administration
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company (2019)
15.2. Company Profiles
15.2.1. AstraZeneca
15.2.2. Boehringer Ingelheim International GmbH
15.2.3. GlaxoSmithKline plc
15.2.4. Novartis AG
15.2.5. Teva Pharmaceutical Industries Ltd
15.2.6. Sumitomo Dainippon Pharma Co., Ltd
15.2.7. Merck & Co., Inc.
15.2.8. F. Hoffmann-La Roche Ltd.
15.2.9. Sanofi
15.2.10. Mylan N.V.
